Arkolith/Insider Trading/AGLE/Form 4

Alspaugh Jonathan

Chief Financial OfficerAeglea BioTherapeutics, Inc. (AGLE) · full profile →Form 4 · filed Jul 8, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2021Grant(A)160K—$0160K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-046007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML